words lines 0 60 0 20 top 50% bottom top 1 0 0 .22 back 1 0 .001 1 .1 1.5 none top bottom center center true 1 none top top center top true 0 200 .001 none
top bottom top center true 1 none top bottom bottom bottom true 1 none

Innovative Medicine Made Accessible to Those in Need

Our Story

Latest News

world
Raman Singh: Delivering Novel Therapies to Improve the Health and Quality of Life of Patients Everywhere – Worlds Leaders
Caris
JUNIPER BIOLOGICS PARTNERS WITH CARIS LIFE SCIENCES® FOR MOLECULAR PROFILING DISTRIBUTION IN SOUTH EAST ASIA
AIawar
Acquisition International Magazine’s M&A Award 2022 for Best Cell & Gene Therapy Acquisition 2022
MoneyFM
CEO Raman Singh speaks about his mission to bring accessibility to the core of pharmaceutical innovation while being committed to ESG.
Juniper_Announcement_Changes
Juniper Biologics Establishes Global Headquarters in Singapore 
legada2
Helsinn Healthcare SA signs exclusive license agreement with Juniper Biologics Pte. Ltd. for LEDAGA® (chlormethine) in Australia, Asia and the Middle East*
Juniper Biologics Healthcare Therapy Oncology Rare Orphan Diseases Gene Therapy Care Gene Therapy Post
Juniper Biologics signs exclusive license agreement with Helsinn for infigratinib (INN) for the emerging markets*
TGCnews2
Juniper Biologics Acquires Cell-Mediated Gene Therapy TG-C LD For Treatment of Knee Osteoarthritis
Juniper Biologics Healthcare Therapy Oncology Rare Orphan Diseases Gene Therapy Grandma
Juniper Biologics In-Licenses Helsinn’s Oncology Portfolio For Aloxi®, Onicit®, Paloxi®, Akynzeo® and Anamorelin (INN)
ceoraman
Juniper Biologics Announces the Appointment of Raman Singh as Chief Executive